Advanced Search:
Equity Index Forex Crypto Commodity

EXAS - Exact Sciences

$71.34  -1.61 (-2.21%)

Updated: 03:09 May 5, 2024 EST

Next Hour's AI Forecast

98.96%

Avg. Accuracy (AI)

$61.83

Next Session's AI Forecast

84.48%

Avg. Accuracy (AI)

$73.15

Next Week's AI Forecast

0%

Trend's Accuracy (AI)

$72.71

Exact Sciences's Position Within the Diagnostics & Research Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

EXACT SCIENCES - HISTORICAL DATA 6M

  • Last price

    $ 71.34

  • Daily change

    $ -1.61

  • Previous Close

    $ 72.95

  • Last Updated

    03:09 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.82 -0.63 0.17 0.05 -0.01

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.82 2.26 2.46 2.29 2.17

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
100% 100% 29.52% 39.36%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
62.38 2.23% 61.02 -6.63% 65.35 1.36% 64.47

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
2.2 47.92 0.8 68.75

Exact Sciences Technical Analysis News

Exact Sciences

5505 Endeavor Lane
Madison, WI 53719
United States
608 284 5700
https://www.exactsciences.com

Sectors: Healthcare
Industry: Diagnostics & Research
F. Time Employees: 6500
Description

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Corporate Governance

Exact Sciences Corporation’s ISS Governance QualityScore as of May 1, 2024 is 4. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 3; Compensation: 7.

EXACT SCIENCES'S HOLDERS RANK

List of holders with stock participation in Exact Sciences.

Holder Rank Holder Shares Date Reported % Out Value